CN103083549A - Medicine composition for treating acute mastitis and preparation method thereof - Google Patents
Medicine composition for treating acute mastitis and preparation method thereof Download PDFInfo
- Publication number
- CN103083549A CN103083549A CN 201210596928 CN201210596928A CN103083549A CN 103083549 A CN103083549 A CN 103083549A CN 201210596928 CN201210596928 CN 201210596928 CN 201210596928 A CN201210596928 A CN 201210596928A CN 103083549 A CN103083549 A CN 103083549A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- medicine composition
- precipice
- newborn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine composition for treating acute mastitis and a preparation method thereof. The medicine composition comprises 1-100 parts of herba lycopi, 1-100 parts of honeysuckle, 1-100 parts of pawpaw, 1-100 parts of bletilla, 1-100 parts of dandelion, 1-100 parts of underground, 1-100 parts of liquorice in parts by weight. The medicine composition for treating acute mastitis has the advantages of being scientific and advanced in compatibility of medicines, having obvious effect on the acute mastitis caused by qi-stagnation inducted blood-stasis, being convenient to take and easy to develop and apply and having highlight clinical significance; and the preparation method of the medicine composition is simple and is easy in operation.
Description
Technical field
The invention belongs to field of traditional Chinese medicine pharmacy, particularly a kind of pharmaceutical composition for the treatment of newborn precipice and preparation method thereof.
Background technology
The breast precipice is the acute festering type disease in breast section of falling ill.Clinical manifestation is breast section caking, swelling pain, and with the whole body heating, after bursting, pus goes out stiff, and Chang Faniu is in women breast-feeding their children, and is especially common with the primipara, is equivalent to the acute mastitis of doctor trained in Western medicine.
The western medical treatment medicine is main mainly with hanging garter, and sulfonamides and antibiotics are generally adopted in newborn precipice of the initial stage for the treatment of at present.The patient causes gastrointestinal reaction, crystalluria, hematuria, erythra, medicine heat and leukopenia sometimes.Specimen can not doublely be controlled, and needs to consume larger financial resources, time, and the medical expense burden is heavy, and relapse rate is high.
Summary of the invention
The present invention develops a kind of pharmaceutical composition for the treatment of newborn precipice through concentrating on studies and clinical practice for many years, comprises herba lycopi 1-100 part, Flos Lonicerae 1-100 part, Fructus Chaenomelis 1-100 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 1-100 part of following weight part ratio.
Further, described pharmaceutical composition comprises herba lycopi 50-100 part, Flos Lonicerae 60-80 part, Fructus Chaenomelis 20-50 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 30-60 part of following weight part ratio.
Further, described pharmaceutical composition also comprises Herba Taraxaci 1-100 part of following weight part ratio, underground 1-100 part and Radix Glycyrrhizae 1-100 part.
Further, described pharmaceutical composition also comprises Herba Taraxaci 50-80 part of following weight part ratio, underground 50-80 part and Radix Glycyrrhizae 30-50 part.
A kind of preparation method for the treatment of the pharmaceutical composition on newborn precipice is characterized in that, the medicine decocting of the side's of getting it filled weight portion 1-3 time.
The present invention treats pharmaceutical composition prescription compatibility science, the advanced person on newborn precipice, to the newborn precipice due to stagnation of QI blood addiction, significant curative effect is arranged, and taking convenience, its production method is simple, and is easy to operate, and easy exploiting is used, and clinical meaning is outstanding.
The specific embodiment
The present invention is described further below in conjunction with embodiment.
Embodiment 1
Medicine of the present invention is comprised of 30 parts, 50 parts of herba lycopis, 60 parts of Flos Loniceraes, 50 parts of Fructus Chaenomeliss, 60 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 80 parts of Herba Taraxacis, underground 50 parts and Radix Glycyrrhizae.
Concrete preparation method is as follows: the medicine decocting of the side's of getting it filled weight portion 3 times.
Usage and dosage: decoction being taken hot, drink and together send down.
The present invention treats newborn precipice 60 examples, cures 48 examples, produce effects 10 examples, average course for the treatment of 5 days.
The above; only be the better specific embodiment of the present invention; but protection scope of the present invention is not limited to this; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to replacement or changed according to technical scheme of the present invention and inventive concept thereof, within all should being encompassed in protection scope of the present invention.
Claims (5)
1. a pharmaceutical composition for the treatment of newborn precipice, is characterized in that, described pharmaceutical composition comprises herba lycopi 1-100 part, Flos Lonicerae 1-100 part, Fructus Chaenomelis 1-100 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 1-100 part of following weight part ratio.
2. the pharmaceutical composition on the newborn precipice for the treatment of according to claim 1, is characterized in that, described pharmaceutical composition comprises herba lycopi 50-100 part, Flos Lonicerae 60-80 part, Fructus Chaenomelis 20-50 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 30-60 part of following weight part ratio.
3. the pharmaceutical composition on the newborn precipice for the treatment of according to claim 1 and 2, is characterized in that, described pharmaceutical composition also comprises Herba Taraxaci 1-100 part of following weight part ratio, underground 1-100 part and Radix Glycyrrhizae 1-100 part.
4. the pharmaceutical composition on the newborn precipice for the treatment of according to claim 3, is characterized in that, described pharmaceutical composition also comprises Herba Taraxaci 50-80 part of following weight part ratio, underground 50-80 part and Radix Glycyrrhizae 30-50 part.
5. a preparation method for the treatment of the pharmaceutical composition on newborn precipice, is characterized in that, the medicine decocting of the side's of getting it filled weight portion 1-3 time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210596928 CN103083549A (en) | 2012-12-26 | 2012-12-26 | Medicine composition for treating acute mastitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210596928 CN103083549A (en) | 2012-12-26 | 2012-12-26 | Medicine composition for treating acute mastitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103083549A true CN103083549A (en) | 2013-05-08 |
Family
ID=48197028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210596928 Pending CN103083549A (en) | 2012-12-26 | 2012-12-26 | Medicine composition for treating acute mastitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103083549A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367826A (en) * | 2014-11-19 | 2015-02-25 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating ischogalactia acute mastitis caused by milk stasis syndrome |
| CN105250711A (en) * | 2015-11-16 | 2016-01-20 | 青岛麦瑞特医药技术有限公司 | Traditional Chinese medicine composition for treating abdominal incision induration after cesarean delivery operation |
-
2012
- 2012-12-26 CN CN 201210596928 patent/CN103083549A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367826A (en) * | 2014-11-19 | 2015-02-25 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating ischogalactia acute mastitis caused by milk stasis syndrome |
| CN105250711A (en) * | 2015-11-16 | 2016-01-20 | 青岛麦瑞特医药技术有限公司 | Traditional Chinese medicine composition for treating abdominal incision induration after cesarean delivery operation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103330809B (en) | Traditional Chinese medicine composition for curing functional uterine bleeding | |
| CN103341103A (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis and preparation method thereof | |
| CN103393913B (en) | Chinese medicinal composition for treating uterine prolapse | |
| CN103083549A (en) | Medicine composition for treating acute mastitis and preparation method thereof | |
| CN103330928A (en) | Traditional Chinese medicine composition used for treating gastric ulcer and preparation method thereof | |
| CN103356925A (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN102397371A (en) | Medicament for treating stomach illness | |
| CN104398915A (en) | Traditional Chinese medicinal composition for chronic eczema | |
| CN103656522A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia | |
| CN104173611A (en) | Traditional Chinese medicinal composition for treating acute glomerulonephritis | |
| CN102846810A (en) | Chinese medicinal preparation for treating threatened abortion | |
| CN106581402A (en) | Traditional Chinese medicine for treating high blood pressure | |
| CN105770624A (en) | Medicated wine for treating rheumatic arthritis | |
| CN104491141A (en) | Traditional Chinese medicine composition for treating blood stasis | |
| CN102462810A (en) | Cervical pain relieving capsule | |
| CN105213959A (en) | The Chinese medicine containing Rhizoma Cyperi (processed) for the treatment of cyclomastopathy | |
| CN104367800A (en) | Traditional Chinese medicine composition for treating agranulocytosis | |
| CN105560558A (en) | Traditional Chinese medicine formula for treating liver and kidney deficiency type gout | |
| CN104138503A (en) | Traditional Chinese medicine for treating lobular hyperplasia of mammary glands | |
| CN104161842A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN102068495A (en) | Capsules for treating cervical spondylosis | |
| CN103599324B (en) | A kind of Chinese medicine for the treatment of joint injury | |
| CN103656083A (en) | Traditional Chinese medicine composition for treating costal chondritis | |
| CN102846813A (en) | Chinese medicinal preparation for treating dysfunctional uterine bleeding | |
| CN101810802A (en) | Chinese medicinal composition for treating pulmonary abscess |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Lin Yang Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Lin Yang Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130508 |